|Daniel D. Von Hoff, MD, FACP, FASCO, FAACR
Professor of Medicine, Mayo Clinic; Physician-in-Chief, Distinguished Professor, Translational Genomics Research Institute (TGEN) ; Virginia G. Piper Distinguished Chair for Innovative Cancer Research and Chief Scientific Officer, Honor Health Research Institute; Chief Scientific Officer, US Oncology; Senior Consultant-Clinical Investigations, City of Hope Los Angeles
|Anthony El-Khoueiry, M.D.
Associate Professor of Clinical Medicine at the Keck School of Medicine of University of Southern California; Director of Clinical Translation at the Southern California Clinical and Translational Science Institute (SC CTSI); Medical Director of the Clinical Investigations Support Office; Director of the Phase 1 Drug Development Program at the USC Norris Comprehensive Cancer Center; Member of the National Cancer Institute Hepatobiliary Cancers Task Force; Chair of the Southwest Oncology Group Hepatobiliary Cancers Subcommittee.
|Hans Loibner, Ph.D.
Former CEO of APEIRON for 13 years. Dr. Loibner holds a PhD in Organic Chemistry from the University of Vienna. Since 1985 he has been engaged in clinically oriented cancer immunotherapy.
|Angela Alistar, M.D.
Medical Director of Gastrointestinal Medical Oncology at Morristown Medical Center and Atlantic Health System Cancer Care.
|Ulrich Granzer, Ph.D.
Ulrich Granzer has a wide range of experience in all aspects of drug development and regulatory affairs, including drug safety and GXP.
|Ruth Ladenstein, M.D.
Associate professor of Pediatrics at the Children’s Cancer Research Institute Vienna (CCRI).
|Holger Lode, M.D.
Holger Lode is Professor and Chair of the Department of General Pediatrics and Pediatric Hematology and Oncology at the University Medicine Greifswald.
|Paul Sondel, M.D., Ph.D.
Reed and Carolee Walker Professor of Pediatrics, Human Oncology, and Genetics; Director of Research, UW Division of Pediatric Hematology, Oncology and BMT, UW Carbone Cancer Center and American Family Children’s Hospital University of Wisconsin
|Marc Albertini, M.D., Ph.D
Associate Professor (with tenure) of Medicine at the Univ of Wisconsin (UW). Dr. Albertini established the UW Carbone Cancer Center Comprehensive Melanoma Clinic in September 1994 and is the leader of the UW Carbone Cancer Center Melanoma Disease-Oriented working group and has also served as Chief of Oncology at the William S. Middleton Memorial Veterans Hospital.
|Pierre L. Triozzi, MD
Professor, Hematology/Oncology & Cancer Biology
*None of the named persons is a member to an executive body of the Company